Cardiac resynchronization therapy and cardiac sympathetic function

Background Cardiac resynchronization therapy (CRT) is an established therapy for advanced congestive heart failure, improving both survival and hospitalization. The mechanism beneath these improvements still needs to be defined as about one-third of the patients do not benefit from resynchronization. Restoration of sympatho-vagal function can play a significant role in the process, but available data are limited. In this scenario, positron emission tomography scans with C-11-hydroxyephedrine, a noradrenaline analogous, has the potential to characterize the modifications of the sympathetic nervous system induced by CRT in decompensated patients. Materials and methods Ten patients (six males, age 6810years) with primary dilated cardiomyopathy were studied before and after resynchronization (acutely and after 3months), from a clinical and echocardiographic point of view. Their cardiac sympathetic nerve activity was evaluated by C-11-hydroxyephedrine positron emission tomography before resynchronization, at short and medium term after resynchronization. Results Responders to CRT (patients showing 15% decrease in left ventricular end-systolic volume) showed a higher level of left ventricular radiotracer uptake both at baseline and after resynchronization with respect to nonresponders. This was coupled with a progressive improvement in homogeneity in left ventricular tracer uptake mainly in responders. Conclusions Cardiac resynchronization therapy improves cardiac sympathetic nerve activity in responders since its activation, while nonresponders do not show any significant change at any time of evaluation. CRT seems to be more effective in those patients with a still structurally preserved, yet functionally impaired, neuroautonomic system.